Hiroko Masuda

3.9k citations

73 papers · 2.9k indexed · 2 hit papers · h-index 26

Impact in

Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways

Papers in

Cancer Research 28
- Breast Cancer Treatment Studies 19
- Cancer, Lipids, and Metabolism 5
Oncology 32
- HER2/EGFR in Cancer Research 10
- Cancer Cells and Metastasis 7
- Cancer Treatment and Pharmacology 7
- Cancer Immunotherapy and Biomarkers 5

Co-authors: Naoto T. Ueno Gabriel N. Hortobágyi Hiroyoshi Doihara Chandra Bartholomeusz Dongwei Zhang Vicente Valero W. Fraser Symmans Ana M. González-Angulo
Journals: Annals of Oncology (4 papers)Cancer Research (4 papers)Breast Cancer (4 papers)Breast Cancer Research and Treatment (4 papers)Clinical Cancer Research (2 papers)
Partner nations: Japan United States Belgium

In The Last Decade

Hiroko Masuda

72 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes 2013 · 525 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Clinical Cancer Research
2012 Breast Cancer Research and Treatment

Peers

Countries citing papers authored by Hiroko Masuda

Since Specialization

Citations

This map shows the geographic impact of Hiroko Masuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Masuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Masuda more than expected).

Fields of papers citing papers by Hiroko Masuda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroko Masuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Masuda. The network helps show where Hiroko Masuda may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hiroko Masuda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hiroko Masuda Line = papers co-authored together Hiroko Masuda links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Real-world progression-free survival and overall survival of palbociclib plus endocrine therapy (ET) in Japanese patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer in the first-line or second-line setting: an observational study Breast Cancer ·Tetsuhiro Yoshinami, Shigenori E. Nagai, Masaya Hattori, Takuho Okamura, Kenichi Watanabe, Takahiro Nakayama, Hiroko Masuda, Michiko Tsuneizumi, Daisuke Takabatake, Michiko Harao, Hiroshi Yoshino, Arne Ax Son Sjöberg, Hiroyuki Yasojima, Danielle Lindemann, Madoka Iwase, Miki Yamaguchi, Takafumi Sangai, Nobuyoshi Kosaka, Candy Caine, Norikazu Masuda	2024	2
2	Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B) The Breast ·Hiroko Masuda, Yuko Tanabe, Zhehong JIN, Koji Matsumoto, Akihiko Shimomura, 刘思辰, Yasuo Miyoshi, Masato Takahashi, Yasuaki Sagara, Shinya Tokunaga, Tsutomu Iwasa, Naoki Niikura, Kenichi Yoshimura, Toshimi Takano, Junji Tsurutani	2023	13
3	Clinical significance of blood endocan level in breast cancer patients The Showa University Journal of Medical Sciences ·Liza Wood, C. Isabela S. Silva, M. Aliramezani, H.H Fiordalisi, Takashi Kuwayama, S. Nishigaki, Hiroko Masuda, Sadako Akashi‐Tanaka, Seigo Nakamura, Yoshinori Katō	2023	1
4	BRCAness as a prognostic indicator in patients with early breast cancer Scientific Reports ·Lei Liu, Stevanus Putra, Junji Tsurutani, Sadako Akashi‐Tanaka, Hiroko Masuda, Yoshimi Ide, S. Nishigaki, Mayuko Inuzuka, Chie Watanabe, H.H Fiordalisi, Terumasa Sawada, V. R. Padole, Ryan B. St James, Takashi Kuwayama, Robert Grossman, A. Phillips, Seigo Nakamura	2020	16
5	Comparison of molecular profile in triple-negative inflammatory and non-inflammatory breast cancer not of mesenchymal stem-like subtype PLoS ONE ·Yohei Funakoshi, Ying Wang, Takashi Semba, Hiroko Masuda, David R. Hout, Naoto T. Ueno, Xiaoping Wang	2019	17
6	Diagnostic performance of dedicated breast PET scanner with a ring detector Annals of Oncology ·Vincent N.Parrillo, Sadako Akashi‐Tanaka, Chiho Watanabe, Hiroko Masuda, H.H Fiordalisi, A. Vishnuprasadh, Yoshimi Ide, Mini Agrawal, Yoshihisa Hirota, 輝樹小泉, Takeshi Sawada, M. Hirose, Seigo Nakamura	2017	1
7	Antitumor Activity of KW-2450 against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases Molecular Cancer Therapeutics ·Kazuharu Kai, Kimie Kondo, Xiaoping Wang, Xuemei Xie, Rongyu Wei, Morisaki Hiroyasu, W. W. Kolb, Hiroko Masuda, Gabriel N. Hortobágyi, Jackylyn E. Baguhin, Hideyuki Saya, Debu Tripathy, Subrata Sen, Naoto T. Ueno	2015	17
8	High HER2/Centromeric Probe for Chromosome 17 Fluorescence In Situ Hybridization Ratio Predicts Pathologic Complete Response and Survival Outcome in Patients Receiving Neoadjuvant Systemic Therapy With Trastuzumab for HER2-Overexpressing Locally Advanced Breast Cancer The Oncologist ·Takahiro Kogawa, Tamer M. Fouad, Diane D. Liu, Jimin Wu, Yu Shen, Hiroko Masuda, Takeo Fujii, Mariana Chávez‐MacGregor, Ricardo H. Álvarez, Gabriel N. Hortobágyi, Vicente Valero, Naoto T. Ueno	2015	23
9	Effect of peginterferon alfa‐2b and ribavirin on hepatocellular carcinoma prevention in older patients with chronic hepatitis C Journal of Gastroenterology and Hepatology ·Takashi Honda, Masatoshi Ishigami, Hiroko Masuda, Yoji Ishizu, Teiji Kuzuya, Kazuhiko Hayashi, Akihiro Ito, Yoshiki Hirooka, Isao Nakano, Tetsuya Ishikawa, Fumihiro Urano, Kentaro Yoshioka, Hidenori Toyoda, Takashi Kumada, Yoshiaki Katano, Hidemi Goto	2014	7
10	Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes Clinical Cancer Research ·Hiroko Masuda, Keith Baggerly, Ying Wang, Ya Zhang, Ana M. González-Angulo, Funda Meric‐Bernstam, Vicente Valero, Brian D. Lehmann, Jennifer A. Pietenpol, Gabriel N. Hortobágyi, W. Fraser Symmans, Naoto T. Ueno Hit paper breakdown →	2013	525
11	Gene expression profiles of inflammatory breast cancer: correlation with response to neoadjuvant chemotherapy and metastasis-free survival Annals of Oncology ·François Bertucci, Naoto T. Ueno, Pascal Finetti, Peter Vermeulen, Anthony Lucci, Fredika M. Robertson, Milton Acosta B, Takayuki Iwamoto, (unknown), Hiroko Masuda, Peter A. van Dam, Wendy A. Woodward, Massimo Cristofanilli, James M. Reuben, Luc Dirix, Patrice Viens, W. Fraser Symmans, Daniel Birnbaum, Steven Van Laere	2013	77
12	Critical Role of the Astrocyte for Functional Remodeling in Contralateral Hemisphere of Somatosensory Cortex after Stroke Journal of Neuroscience ·Yusuke Takatsuru, Kei Eto, Ryosuke Kaneko, Hiroko Masuda, Noriaki Shimokawa, Noriyuki Koibuchi, Junichi Nabekura	2013	50
13	Ileal perforation induced by acute radiation injury under gefitinib treatment International Journal of Clinical Oncology ·Takayuki Muraoka, Kazunori Tsukuda, Shinichi Toyooka, Shunsuke Kagawa, Yoshio Naomoto, Mitsuhiro Takemoto, Kuniaki Katsui, Susumu Kanazawa, Yuho Maki, Hiroko Masuda, Masaaki Harada, Hiroaki Asano, Masahiro Murakoshi, Shinichiro Miyoshi	2011	10
14	Functional interaction of fibroblast growth factor-8, bone morphogenetic protein and estrogen receptor in breast cancer cell proliferation Molecular and Cellular Endocrinology ·Hiroko Masuda, Fumio Otsuka, Yoshinori Matsumoto, بشلاغم يحيى, Tomoko Miyoshi, Kenichi Inagaki, Tadahiko Shien, Naruto Taira, Hirofumi Makino, Hiroyoshi Doihara	2011	13
15	Predictive factors for the effectiveness of neoadjuvant chemotherapy and prognosis in triple-negative breast cancer patients Cancer Chemotherapy and Pharmacology ·Hiroko Masuda, Norikazu Masuda, Yoshinori Kodama, Masami Ogawa, 渡辺和之, Jun Yamamura, Kazunori Tsukuda, Hiroyoshi Doihara, Shinichiro Miyoshi, Masayuki Mano, Shoji Nakamori, Toshimasa Tsujinaka	2010	55
16	Size-related changes in photosynthesis and leaf characteristics in Sabina vulgaris Ant in the Mu-us Desert, Inner Mongolia, China Journal of the Japanese Society of Revegetation Technology ·Kenzo Tanaka, Isabelle Desriaux, Hiroko Masuda, Ikuo Ninomiya, Linhe Wang, Ken Yoshikawa	2006	2
17	β-Catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone Biochemical and Biophysical Research Communications ·Hiroko Natsume, Shigekazu Sasaki, Masatoshi Kitagawa, Yumiko Kashiwabara, Akio Matsushita, Keiko Nakano, Kozo Nishiyama, Koji Nagayama, Hiroko Misawa, Hiroko Masuda, Hirotoshi Nakamura	2003	42
18	Expression and localization of collagen-binding stress protein Hsp47 in mouse embryo development: comparison with types I and II collagen Cell Stress and Chaperones ·Hiroko Masuda, Nobuko Hosokawa, Kazuhiro Nagata	1998	40
19	Expression of 47 kDa Heat Shock Protein (HSP47) during Development of Mouse Cornea Experimental Eye Research ·Yasuyuki Tanaka, Kappei Kobayashi, Masakazu Kita, Hiroko Masuda, Shigeru Kinoshita, Kazuhiro Nagata, Jirô Imanishi	1996	16
20	Visual pigments in the pineal complex of the Japanese quail, Japanese grass lizard and bullfrog: Immunocytochemistry and HPLC analysis Tissue and Cell ·Hiroko Masuda, Tadashi Oishi, Shramika H. Jamhale, Maulidatur Rohmah, Yoshitaka Fukada, Y. Shichida, Toru Yoshizawa	1994	33

About Hiroko Masuda

Hiroko Masuda is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Hepatology and Toxicology, having authored 73 papers that have together received 2.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (19 papers), HER2/EGFR in Cancer Research (10 papers), Cancer Cells and Metastasis (7 papers), Cancer Treatment and Pharmacology (7 papers), Advanced Breast Cancer Therapies (6 papers), Cancer, Lipids, and Metabolism (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Ferroptosis and cancer prognosis (4 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.3k citations), Molecular Medicine (93 citations), Molecular Biology (1.1k citations) and Pulmonary and Respiratory Medicine (489 citations). Hiroko Masuda has collaborated with scholars based in Japan, United States and Belgium. Frequent co-authors include Naoto T. Ueno, Gabriel N. Hortobágyi, Hiroyoshi Doihara, Chandra Bartholomeusz, Dongwei Zhang, Vicente Valero, W. Fraser Symmans, Ana M. González-Angulo, K. Nagata and Kazunori Hirayoshi. Their work appears in journals such as Annals of Oncology, Cancer Research, Breast Cancer, Breast Cancer Research and Treatment and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact